We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.69B
AUM Growth
-$187M
Cap. Flow
-$186M
Cap. Flow %
-11.04%
Top 10 Hldgs %
22.67%
Holding
154
New
18
Increased
32
Reduced
44
Closed
32

Top Buys

Rank Stock Value
1
DOX icon
Amdocs
DOX
+$36M
2
PG icon
Procter & Gamble
PG
+$24.9M
3
GLW icon
Corning
GLW
+$18.7M
4
CARR icon
Carrier Global
CARR
+$17.4M
5
DD icon
DuPont de Nemours
DD
+$17.2M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$36.2M
2
MET icon
MetLife
MET
+$32.7M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$30.6M
4
PAYX icon
Paychex
PAYX
+$27.6M
5
ADM icon
Archer Daniels Midland
ADM
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 16.45%
2 Technology 14.49%
3 Financials 13.6%
4 Industrials 10.79%
5 Consumer Staples 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GD icon
26
General Dynamics
GD
$105B
$24M 1.42%
105,380
-68,950
-40% -$15.9M
ABBV icon
27
AbbVie
ABBV
$458B
$23.6M 1.4%
148,340
-59,930
-29% -$9.16M
GIS icon
28
General Mills
GIS
$19.2B
$23.5M 1.39%
275,380
-140,420
-34% -$11.2M
ETN icon
29
Eaton
ETN
$157B
$23.5M 1.39%
137,300
– –
ABT icon
30
Abbott
ABT
$180B
$22.5M 1.33%
222,290
+110,060
+98% +$11.6M
GS icon
31
Goldman Sachs
GS
$313B
$22.4M 1.33%
68,460
-800
-1% -$278K
DHR icon
32
Danaher
DHR
$135B
$22.3M 1.32%
99,580
+1,128
+1% +$257K
DUK icon
33
Duke Energy
DUK
$102B
$21M 1.24%
217,190
– –
BAC icon
34
Bank of America
BAC
$435B
$20.4M 1.21%
714,930
-132,160
-16% -$4.36M
CSCO icon
35
Cisco
CSCO
$450B
$20.4M 1.21%
390,210
+227,600
+140% +$11.1M
EPD icon
36
Enterprise Products Partners
EPD
$83.8B
$20.2M 1.2%
780,370
– –
RSG icon
37
Republic Services
RSG
$66.7B
$19.7M 1.17%
145,780
-173,670
-54% -$22.2M
TGT icon
38
Target
TGT
$62.1B
$19.5M 1.15%
117,600
-26,800
-19% -$4.41M
ORCL icon
39
Oracle
ORCL
$331B
$19.3M 1.14%
207,660
+160,960
+345% +$14.1M
JNJ icon
40
Johnson & Johnson
JNJ
$635B
$19.1M 1.13%
123,400
+5,400
+5% +$872K
GLW icon
41
Corning
GLW
$126B
$19M 1.12%
+537,560
New +$18.7M
ELV icon
42
Elevance Health
ELV
$81.9B
$18.8M 1.11%
40,900
-27,000
-40% -$12.8M
IVW icon
43
iShares S&P 500 Growth ETF
IVW
$72.5B
$18.8M 1.11%
293,671
+49,941
+20% +$3.05M
RTX icon
44
RTX Corp
RTX
$287B
$18.3M 1.08%
186,580
+57,400
+44% +$5.65M
DOV icon
45
Dover
DOV
$27.2B
$18.1M 1.07%
119,380
+116,700
+4,354% +$17.1M
CARR icon
46
Carrier Global
CARR
$57.2B
$17.8M 1.05%
+389,300
New +$17.4M
SPG icon
47
Simon Property Group
SPG
$74.5B
$17.7M 1.05%
158,350
– –
DD icon
48
DuPont de Nemours
DD
$18.6B
$17.4M 1.03%
192,793
+188,969
+4,942% +$17.2M
AMGN icon
49
Amgen
AMGN
$203B
$17.1M 1.01%
70,540
+69,440
+6,313% +$17M
AMAT icon
50
Applied Materials
AMAT
$426B
$16.7M 0.99%
+135,610
New +$15.6M
1
2
3 4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q1 2023 Portfolio in Review

As of Q1 2023, Payden & Rygel held 154 positions worth $1.69B, down 10% from $1.88B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Payden & Rygel withdrew a net $186M in Q1 2023, closing 32 positions and reducing 44 holdings. Its most notable exit was Paychex, an estimated $27.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

Against the trend, Payden & Rygel opened a new position in Amdocs worth $37.4M.

  • Payden & Rygel's largest Q1 2023 buy was Amdocs: 389,000 shares worth $37.4M.
  • Payden & Rygel added most to DuPont de Nemours in Q1 2023, an estimated $17.2M increase.
  • Payden & Rygel's biggest Q1 2023 reduction was CVS Health, cutting an estimated $36.2M.
  • Payden & Rygel fully exited Paychex in Q1 2023, selling an estimated $27.6M.
  • Payden & Rygel's ten largest holdings make up 23% of its $1.69B portfolio in Q1 2023.
  • Payden & Rygel opened 18 new positions and closed 32 in Q1 2023.
  • Payden & Rygel's portfolio value fell 10% quarter-over-quarter to $1.69B.

Based on Payden & Rygel's 13F filing for Q1 2023, filed 10 May 2023.